Pharmaceutical Executive is categorized under Periodical Publishers in New York City, NY .
Pharmaceutical Executive was established in 0, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Periodical Publishers business, which does work in the B2B market, and is classified as a Periodical Publishers, under code number 5111200 by the NAICS.
If you are seeking more information, feel free to contact Jay Berfas, Manager at the company’s single location by writing to 641 Lexington Avenue Floor 8, New York City, New York NY 10022 or by phoning (212) 951-6600. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pharmaceutical Executive |
| Contact Person: | Jay Berfas, Manager |
| Address: | 641 Lexington Avenue Floor 8, New York City, New York 10022 |
| Phone Number: | (212) 951-6600 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Periodical Publishers |
| SIC Code: | 2721 |
| NAICS Code: | 5111200 |
| Share This Business: |
Pharmaceutical Executive was started in 0 to provide professional Periodical Publishers under the SIC code 2721 and NAICS code 5111200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Jay Berfas, Manager for inquiries that concern Pharmaceutical Executive by calling the company number (212) 951-6600, as your correspondence is most welcome. Additionally, the physical location of the single location of Pharmaceutical Executive can be found at the coordinates 40.759124,-73.970361 as well as the street address 641 Lexington Avenue Floor 8 in New York City, New York 10022.
For its online presence, you may visit Pharmaceutical Executive’s website at and engage with its social media outlets through on Twitter and on Facebook.